ICU MEDICAL INC (ICUI) Stock Fundamental Analysis
USA - NASDAQ:ICUI - US44930G1076 - Common Stock
123.46 USD
+1.79 (+1.47%)
ICUI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ICUI while its profitability can be described as average. ICUI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
In the past year ICUI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ICUI (-0.90%) is better than 70.53% of its industry peers.
ICUI's Return On Equity of -1.75% is fine compared to the rest of the industry. ICUI outperforms 71.58% of its industry peers.
With a decent Return On Invested Capital value of 2.81%, ICUI is doing good in the industry, outperforming 71.05% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 8.88%.
The last Return On Invested Capital (2.81%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.75% | ||
| ROIC | 2.81% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
With a decent Operating Margin value of 5.43%, ICUI is doing good in the industry, outperforming 70.53% of the companies in the same industry.
In the last couple of years the Operating Margin of ICUI has declined.
ICUI has a Gross Margin of 35.84%. This is in the lower half of the industry: ICUI underperforms 71.05% of its industry peers.
In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.43% | ||
| PM (TTM) | N/A | ||
| GM | 35.84% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
The number of shares outstanding for ICUI has been increased compared to 1 year ago.
Compared to 5 years ago, ICUI has more shares outstanding
ICUI has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.03 indicates that ICUI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ICUI (2.03) is comparable to the rest of the industry.
ICUI has a debt to FCF ratio of 26.58. This is a negative value and a sign of low solvency as ICUI would need 26.58 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 26.58, ICUI is doing good in the industry, outperforming 70.00% of the companies in the same industry.
ICUI has a Debt/Equity ratio of 0.63. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, ICUI is not doing good in the industry: 66.84% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 26.58 | ||
| Altman-Z | 2.03 |
ROIC/WACC0.38
WACC7.32%
2.3 Liquidity
ICUI has a Current Ratio of 2.44. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
ICUI has a Current ratio (2.44) which is in line with its industry peers.
A Quick Ratio of 1.17 indicates that ICUI should not have too much problems paying its short term obligations.
ICUI has a Quick ratio of 1.17. This is in the lower half of the industry: ICUI underperforms 69.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
ICUI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.86%, which is quite impressive.
The Earnings Per Share has been decreasing by -5.28% on average over the past years.
Looking at the last year, ICUI shows a small growth in Revenue. The Revenue has grown by 2.96% in the last year.
Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)32.86%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%34.62%
Revenue 1Y (TTM)2.96%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-6.44%
3.2 Future
The Earnings Per Share is expected to grow by 17.18% on average over the next years. This is quite good.
ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.96% yearly.
EPS Next Y14.6%
EPS Next 2Y15.15%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.96%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.42, ICUI is valued correctly.
ICUI's Price/Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 85.79% of the companies in the same industry.
When comparing the Price/Earnings ratio of ICUI to the average of the S&P500 Index (26.83), we can say ICUI is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.97, ICUI is valued correctly.
ICUI's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 86.84% of the companies in the same industry.
ICUI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.42 | ||
| Fwd PE | 14.97 |
4.2 Price Multiples
ICUI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ICUI is cheaper than 85.79% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICUI is valued a bit cheaper than 74.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.35 | ||
| EV/EBITDA | 12.02 |
4.3 Compensation for Growth
ICUI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ICUI's earnings are expected to grow with 15.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.12
PEG (5Y)N/A
EPS Next 2Y15.15%
EPS Next 3Y15.92%
5. Dividend
5.1 Amount
ICUI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ICUI (10/24/2025, 10:10:57 AM)
123.46
+1.79 (+1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners113.8%
Inst Owner Change0.01%
Ins Owners0.98%
Ins Owner Change-1.3%
Market Cap3.05B
Revenue(TTM)2.37B
Net Income(TTM)-36949000
Analysts83.33
Price Target181.36 (46.9%)
Short Float %6.07%
Short Ratio4.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.5%
Min EPS beat(2)31.74%
Max EPS beat(2)37.25%
EPS beat(4)4
Avg EPS beat(4)33.31%
Min EPS beat(4)24.67%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)30.18%
EPS beat(12)12
Avg EPS beat(12)24.5%
EPS beat(16)15
Avg EPS beat(16)18.53%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.09%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-0.01%
Revenue beat(12)6
Avg Revenue beat(12)-0.81%
Revenue beat(16)8
Avg Revenue beat(16)-0.38%
PT rev (1m)0%
PT rev (3m)-5.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.57%
EPS NY rev (1m)0%
EPS NY rev (3m)5.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.42 | ||
| Fwd PE | 14.97 | ||
| P/S | 1.28 | ||
| P/FCF | 60.35 | ||
| P/OCF | 21.96 | ||
| P/B | 1.44 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.02 |
EPS(TTM)7.52
EY6.09%
EPS(NY)8.25
Fwd EY6.68%
FCF(TTM)2.05
FCFY1.66%
OCF(TTM)5.62
OCFY4.55%
SpS96.09
BVpS85.69
TBVpS-3.41
PEG (NY)1.12
PEG (5Y)N/A
Graham Number120.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.75% | ||
| ROCE | 3.56% | ||
| ROIC | 2.81% | ||
| ROICexc | 3.06% | ||
| ROICexgc | 9.06% | ||
| OM | 5.43% | ||
| PM (TTM) | N/A | ||
| GM | 35.84% | ||
| FCFM | 2.13% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 26.58 | ||
| Debt/EBITDA | 3.98 | ||
| Cap/Depr | 42.51% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 41.23% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.03 |
F-Score7
WACC7.32%
ROIC/WACC0.38
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.86%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%34.62%
EPS Next Y14.6%
EPS Next 2Y15.15%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue 1Y (TTM)2.96%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-6.44%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.96%
EBIT growth 1Y118.78%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year37.73%
EBIT Next 3Y15.54%
EBIT Next 5Y10.05%
FCF growth 1Y216.11%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y243.63%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
What is the valuation status of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
How profitable is ICU MEDICAL INC (ICUI) stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 14.6% in the next year.